Skip to content

Braveheart Bio

US · BRVE #2845 by market cap Listed 2026
20.39 +1.12 +5.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 19.29 +0.10%
After-hours 20.39 0.00%
30.0017.4220.392026-08-062026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on BRVE?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -25.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 5.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is above its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W +3.92%
1M +0.59%
3M -25.64%

Key statistics

Price & volume

Prev close
19.27
Open
19.29
Day range
18.83 - 21.16
Avg price
20.35
Volume
866.73K
Turnover
17.64M
Amplitude
12.12%
52-week range
16.70 - 32.00

Valuation

P/E
-21.81
P/E (TTM)
-27.82
P/B
3.68
EPS
-0.94
Net profit
-84.03M
Net assets
497.61M

Share structure

Market cap
1.83B
Float cap
382.31M
Shares out
89.87M
Float shares
18.75M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-08-06
52-week range 24% of range
16.70 32.00

36.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+1.83M net over the window

Short interest

Shares short
5.15M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Braveheart Bio (BRVE)?

Braveheart Bio last traded at 20.39. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Braveheart Bio's market cap?

About 1.83B.

What is the P/E ratio of Braveheart Bio?

The trailing twelve-month P/E is -27.82. The Valuation tab shows it against the stock's own five-year range.

Does Braveheart Bio pay a dividend?

Braveheart Bio does not currently pay a regular dividend.

Is Braveheart Bio a buy according to analysts?

The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 45.50, which implies 123.1% upside from the current price. This is not investment advice.

What is Braveheart Bio's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Braveheart Bio a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Braveheart Bio discussion 0 comments

Add a comment